These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15803397)

  • 1. Determining the optimal size of small molecule mixtures for high throughput NMR screening.
    Mercier KA; Powers R
    J Biomol NMR; 2005 Mar; 31(3):243-58. PubMed ID: 15803397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of small molecule libraries for NMR screening and other applications in drug discovery.
    Jacoby E; Davies J; Blommers MJ
    Curr Top Med Chem; 2003; 3(1):11-23. PubMed ID: 12570776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of (1)H NMR to facilitate solubility measurement for drug discovery compounds.
    Lin M; Tesconi M; Tischler M
    Int J Pharm; 2009 Mar; 369(1-2):47-52. PubMed ID: 19073245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR-based screening methods for lead discovery.
    Vogtherr M; Fiebig K
    EXS; 2003; (93):183-202. PubMed ID: 12613177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput nuclear magnetic resonance-based screening.
    Hajduk PJ; Gerfin T; Boehlen JM; Häberli M; Marek D; Fesik SW
    J Med Chem; 1999 Jul; 42(13):2315-7. PubMed ID: 10395471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of NMR screening in drug discovery.
    Fejzo J; Lepre C; Xie X
    Curr Top Med Chem; 2003; 3(1):81-97. PubMed ID: 12570779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting data from high-throughput screening of small-molecule libraries.
    Inglese J; Shamu CE; Guy RK
    Nat Chem Biol; 2007 Aug; 3(8):438-41. PubMed ID: 17637769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR screening in drug discovery.
    Moore JM
    Curr Opin Biotechnol; 1999 Feb; 10(1):54-8. PubMed ID: 10047510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Industrial medicinal chemistry insights: neuroscience hit generation at Janssen.
    Tresadern G; Rombouts FJR; Oehlrich D; Macdonald G; Trabanco AA
    Drug Discov Today; 2017 Oct; 22(10):1478-1488. PubMed ID: 28669605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of an ADME enabling selection and visualization tool for drug discovery.
    Stoner CL; Gifford E; Stankovic C; Lepsy CS; Brodfuehrer J; Prasad JV; Surendran N
    J Pharm Sci; 2004 May; 93(5):1131-41. PubMed ID: 15067690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment-based activity space: smaller is better.
    Hesterkamp T; Whittaker M
    Curr Opin Chem Biol; 2008 Jun; 12(3):260-8. PubMed ID: 18316043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and dynamic properties of amorphous solid dispersions: the role of solid-state nuclear magnetic resonance spectroscopy and relaxometry.
    Paudel A; Geppi M; Mooter GVD
    J Pharm Sci; 2014 Sep; 103(9):2635-2662. PubMed ID: 24715618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound aggregation in drug discovery: implementing a practical NMR assay for medicinal chemists.
    LaPlante SR; Carson R; Gillard J; Aubry N; Coulombe R; Bordeleau S; Bonneau P; Little M; O'Meara J; Beaulieu PL
    J Med Chem; 2013 Jun; 56(12):5142-50. PubMed ID: 23730910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technological advances in high-throughput screening.
    Liu B; Li S; Hu J
    Am J Pharmacogenomics; 2004; 4(4):263-76. PubMed ID: 15287820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR spectroscopy and surface tension measurements applied to the study of self-association of casopitant mesylate, a novel NK1 antagonist.
    Provera S; Beato S; Cimarosti Z; Turco L; Casazza A; Caivano G; Marchioro C
    J Pharm Biomed Anal; 2011 Jan; 54(1):48-52. PubMed ID: 20813479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of mixture distributions to deconvolute the behavior of "hits" and controls in high-throughput screening data.
    Buxser S; Chapman DL
    Anal Biochem; 2007 Feb; 361(2):197-209. PubMed ID: 17214952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current NMR Techniques for Structure-Based Drug Discovery.
    Sugiki T; Furuita K; Fujiwara T; Kojima C
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29329228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NanoStore: a concept for logistical improvements of compound handling in high-throughput screening.
    Benson N; Boyd HF; Everett JR; Fries J; Gribbon P; Haque N; Henco K; Jessen T; Martin WH; Mathewson TJ; Sharp RE; Spencer RW; Stuhmeier F; Wallace MS; Winkler D
    J Biomol Screen; 2005 Sep; 10(6):573-80. PubMed ID: 16103412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-stoichiometric inhibition in integrated lead finding - a literature review.
    Klumpp M
    Expert Opin Drug Discov; 2016; 11(2):149-62. PubMed ID: 26653534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyphenated HPLC-NMR and its applications in drug discovery.
    Peng SX
    Biomed Chromatogr; 2000 Oct; 14(6):430-41. PubMed ID: 11002280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.